Ranbaxy Pharmaceuticals Canada Inc. (RPCI) is engaged in the sale and distribution of affordable generic medicines in the Canadian healthcare system. Ranbaxy's R&D efficiencies and globally integrated systems enable RPCI to develop and manufacture pharmaceuticals to be brought to market quickly, efficiently, and at lower costs. As a result, we anticipate making a meaningful contribution to the healthcare system in Canada, as in other countries where we have done business.